AMED Financial Facts
Miscellaneous, net: 1.71MEquity in earnings from unconsolidated joint ventures: 3.24M
See Full Income Statement
Prepaid expenses: 9.95M
Total Amedisys, Inc. stockholders' equity: 445.45M
See Full Balance Sheet
Amedisys (AMED) Earnings
|
Expand Research on AMED
| Next EPS Date | 5/1/24 | EPS Growth Rate | +2.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +5.0% | Revenue Growth Rate | +1.6% |
| Average % Move 1-Wk after EPS | -1.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/13  |
 |
Q412 | $0.24 | $0.22 | +$0.02 | $632.9M | $373.31M | = |  | | Details |
| 2/21/24 | Q423 | $0.94 | $1.03 | -$0.09 | $570.8M | $567.4M | N/A | | | Details | |
| 8/4/21 | |
Q221 | $1.69 | $1.67 | +$0.02 | $564.2M | $566.19M | = | | | Details |
| 2/15/23 | Q422 | $1.16 | $0.98 | +$0.18 | $562.06M | $560.59M | = | | | Details | |
| 2/23/22 | |
Q421 | $1.18 | $1.18 | $0.00 | $559.3M | $555.2M | = | | | Details |
| 7/27/22 | Q222 | $1.47 | $1.23 | +$0.24 | $557.9M | $583.12M | = | | | Details | |
| 5/3/23 | Q123 | $1.00 | $0.89 | +$0.11 | $556.4M | $558.81M | = | | | Details | |
| 10/24/23 |
Q323 | $0.98 | $1.08 | -$0.10 | $556.24M | $560.59M | = | | | Details |
